schizandrin has been researched along with Adjuvant Arthritis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, G; Liang, L; Lin, W; Liu, D; Liu, Y; Qiu, Q; Shen, C; Shi, M; Wang, C; Xiao, Y; Xu, H; Xu, M; Xu, S; Zhang, S | 1 |
1 other study(ies) available for schizandrin and Adjuvant Arthritis
| Article | Year |
|---|---|
Schisandrin treatment suppresses the proliferation, migration, invasion, and inflammatory responses of fibroblast-like synoviocytes from rheumatoid arthritis patients and attenuates synovial inflammation and joint destruction in CIA mice.
Topics: Animals; Antirheumatic Agents; Arthritis, Experimental; Arthritis, Rheumatoid; Cell Movement; Cell Proliferation; Cells, Cultured; Fibroblasts; Inflammation; Interleukin-6; Interleukin-8; Mice; NF-kappa B; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Synoviocytes; Tumor Necrosis Factor-alpha | 2023 |